West Pharmaceutical Services, Inc. News
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
see moreWest Pharmaceutical Services, Inc. Market News
5d
West Pharmaceutical (WST) Sees Insider Stock Sales Amid Quiet Recent Developments
- Insider Form 4 filings show WST executives sold shares this week, while no new company news in pharma packaging emerged in the past 7 days.
12d
West Pharmaceutical Services Signs Cross‑License and Distribution Deal with Daikyo Seiko
West Pharmaceutical Services (WST) and Daikyo Seiko have entered into a cross‑license and distributorship agreement, marking a strategic expansion in drug‑delivery technologies.
19d
Institutional Investors Increase Holdings in West Pharmaceutical Services Amid Stable Market Conditions
Multiple institutional investors built new positions in West Pharmaceutical Services (WST) in the past week, signaling growing confidence in the medical instruments supplier.
26d
Evercore Lifts Price Target on WST Amid Margin Improvement Momentum
Evercore ISI raises West Pharmaceutical Services price target to $425 as Q2 margin narrative gains traction alongside GLP‑1 demand.
17 Aug at 17:05
West Pharmaceutical Services Reports Q2 2026 Earnings Amid Leadership Transition
West Pharmaceutical Services announces Q2 2026 earnings and CEO transition.